Skip to content

Williams v. Boehringer Ingelheim Pharmaceuticals, Inc.

Petition for certiorari denied on February 20, 2024

Docket No. Op. Below Argument Opinion Vote Author Term
23-267 11th Cir. N/A N/A N/A N/A OT 2023

Issue: Whether an interlocutory ruling that dismisses some (but not all) of a plaintiff"s claims with prejudice become an appealable "final decision" if the plaintiff voluntarily dismisses her action under Federal Rule of Civil Procedure 41(a).

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
07/25/2023Application (23A79) to extend the time to file a petition for a writ of certiorari from August 16, 2023 to October 15, 2023, submitted to Justice Thomas.
07/27/2023Application (23A79) granted by Justice Thomas extending the time to file until September 15, 2023.
09/15/2023Petition for a writ of certiorari filed. (Response due October 20, 2023)
10/16/2023Waiver of right of respondents Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp. to respond filed.
11/01/2023DISTRIBUTED for Conference of 11/17/2023.
11/06/2023Response Requested. (Due December 6, 2023)
11/13/2023Motion to extend the time to file a response from December 6, 2023 to December 22, 2023, submitted to The Clerk.
11/14/2023Motion to extend the time to file a response is granted and the time is extended to and including December 22, 2023.
12/21/2023Brief of respondents Boehringer Ingelheim Pharmaceuticals, Inc. et al. in opposition filed.
01/04/2024Reply of petitioner Marilyn Williams filed.
01/10/2024DISTRIBUTED for Conference of 2/16/2024.
02/20/2024Petition DENIED.